FDA Inspection 1123965 — Mark S. Lee, M.D.
The FDA completed an inspection of Mark S. Lee, M.D. on May 29, 2020 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 29, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Antonio, TX (United States)
Additional Details
Clinical Investigator (CI)